We have previously demonstrated the presence of a corticosteroid-binding protein (CBP) in Candida albicans and speculated on its homology to the glucocorticoid receptor. To explore this relationship further, we cloned the CBP gene. Our strategy employed sequencing enzymaticafly derived peptide fragments from purified CBP and using this information to synthesize degenerate oligonucleotide primers for use in the PCR. A 117-bp f ent amplfied from C.
).
We and others have previously demonstrated the presence in several fungi of steroid-binding proteins (SBPs) that exhibit high affinity and specificity for vertebrate steroid hormones (7) . A corticosteroid-binding protein (CBP) showing high affinity for both corticosterone and progesterone has been described in C. albicans (8) (9) (10) (11) ). An estrogen-binding protein (EBP) has been demonstrated in C. albicans (12, 13) , Sac- charomyces cerevisiae (14, 15) , and Paracoccidioides brasieliensis (16, 17) . A progesterone-binding protein (PBP) has been shown in Trichophyton mentagrophytes and other dermatophytes (18) (19) (20) . In the latter three organisms, biological responses were detected after direct in vitro treatment with steroid hormones that bind to the SBPs, but no responses were found after treatment of the organisms with nonbinding hormones. Specifically, treatment of P. brasiliensis with estradiol inhibited conversion from mycelial form to yeast form (16, 17, 21, 22) , treatment of T. mentagrophytes with progesterone inhibited growth (18) (19) (20) 23) , and treatment of S. cerevisiae with estradiol regulated the cell cycle (24) . Although no physiological response to corticosteroids has yet been definitively demonstrated in C. albicans, preliminary reports suggest that such effects occur, including increased adhesion to vaginal epithelial cells after treatment with progesterone (25) and growth inhibition after treatment with corticosterone.t In addition, there has been clinical documentation that the therapeutic administration of corticosteroids to patients increases the incidence of Candida infection (26) . Also, factors that increase sex steroid hormone levels, such as the menstrual cycle stage, pregnancy, and the use of birth control pills, lead to a rise in the incidence of Candida vaginal infections (26, 27) . These clinical observations, combined with our laboratory findings, have led us to speculate that the hormonal environment of the host, acting by means of the CBP and/or EBP, may affect the pathogenicity of C. albicans (7) . Although host defenses clearly are altered by steroid hormone actions, the SBP hypothesis suggests that hormones produced by or administered to the host may have direct actions on the invading pathogen as well.
Additionally, we have speculated that the SBPs may represent ancestral receptors that are evolutionarily conserved and related to the vertebrate steroid receptors (7) . Analysis of the evolutionary relationship of members of the steroid receptor gene superfamily showed that they were derived from a single primordial gene that long predated mammals (28) . Ifthe SBPs were related to the primordial gene, then the ability ofvertebrate steroids to bind to the fungal SBPs would be not fortuitous but the result of conserved sequences in homologous genes. The cloning of the SBP genes should provide direct evidence to indicate whether the fungal SBPs are evolutionarily related to the steroid receptor gene superfamily (29) (starting mass of 900 g wet weight) by sequential chromatography on DEAE-Sephacel, hydroxylapatite, and a cortico-Proc. Natl. Acad. Sci. USA 90 (1993) 1903 sterone affinity column. The purified protein was digested with endoproteinase Asp-N, and gas-phase microsequencing (30) was used to obtain amino acid sequences from three peptide fragments. On the basis of the peptide sequence, degenerate deoxyoligonucleotide primers were synthesized and used in the PCR amplification of C. albicans DNA. The reaction sample contained 50 mM Tris HCl at pH 7.9, 100 mM KCI, 2 mM MgCl2, 0.5 mg of C. albicans DNA, and 1 pg each of the primers. After heating at 94°C for 7 min and addition of 5 units of Taq DNA polymerase, the reaction was cycled 30 times at 94°C for 1 min, 55°C for 1.5 min, and 72°C for 3 min, after which time the sample was incubated at 72°C for 10 min. A 117-bp DNA fragment was generated and treated with the Klenow fragment of DNA polymerase and inserted into the HinclI site of the plasmid vector pBluescript II KS (+) (Stratagene). The DNA sequence ofthe PCR product was determined by dideoxy double-strand DNA sequencing (31) using Sequenase (United States Biochemical). The PCR product was labeled with [a-32P]dCTP by the random primer method and then used to screen a AEMBL3 C. albicans genomic library (32) . DNA inserts from plaque-purified clones were subcloned in pBluescript II KS (+) for restriction enzyme mapping and DNA sequencing.
Gene (35) at 550C, the membrane was incubated at 550C with 32P-labeled Pst I-BamHI DNA fragnent of pCBP. The blot was washed in 0.15 M NaCl/ 0.015 M sodium citrate, pH 7.0/5% SDS at 550C and exposed to Kodak XAR film at -70°C.
Southern Analysis. C. albicans DNA was digested with several restriction endonucleases, electrophoresed on 1% agarose gels, and transferred to nylon (36) . The membrane was hybridized with the 32P-labeled probe as described above.
Computer Analysi of DNA and Protein Sequence. Computer analyses of the DNA and amino acid sequences were performed with the Genetics Computer Group software package from the University of Wisconsin (37) 
RESULTS
Cloning and Characterization of the Gene Encoding the C. albicans CBP. To clone the C. albicans CBP gene, amino acid sequences were first obtained from three peptide fragments generated by endoproteinase digestion of purified CBP. Oligonucleotides based upon the amino acid sequences were synthesized, and these were used as primers to amplify the C. albicans CBP gene by the PCR. A 117-bp DNA fragment was amplified from one set of primer pairs, which was sequenced and shown to encode 7 of 8 and 11 of 12 amino acids of the two peptide sequences used to synthesize the primers. The amino acid mismatches were considered to be errors in the protein sequence analysis. To isolate the entire CBP gene, we used the 117-bp PCR product to screen a C. albicans genomic library (32) . Five positive clones were obtained. One clone, designated 3.2A, was chosen for further study, and a restriction map is shown in Fig. 1A . Restriction fragnents which hybridized to the PCR probe were subcloned in pBluescript II KS (+) and both strands were sequenced (31) . The DNA sequencing strategy and the location of the CBP ORE are shown in Fig. 1 . The nucleotide sequence and the deduced amino acid sequence are shown in Fig. 2 (Fig. 1B) . As shown in Fig. 3A , a single transcript of approximately 1.8 kb was detected, thus demonstrating that the CBP gene is transcribed in C. albicans. In addition, the mRNA levels appeared equivalent in the yeast and mycelial forms, which is in agreement with the findings of previous C. albicans [3H] corticosterone binding experiments (9) . The abundance of CBP mRNA increases during the late-logarithmic growth phase of the organism and the levels were not changed when the cells were exposed to corticosterone (data not shown).
When Southern blots of C. albicans DNA were probed with the Pst I-BamHI DNA fragment, a major hybridizing band was visualized in each of the restriction digests, suggesting that this gene is present at a unique locus within the C. albicans genome (Fig. 3B) . A faint second band of hybridization was also observed in several digests, suggesting the possible presence of a related gene. A Southern blot with S. cerevisiae DNA, hybridized and washed at the same stringency used for the C. albicans blots, showed no bands of hybridization (data not shown). A Southern blot of C. albicans chromosomes (strain A501) separated by pulsedfield gel electrophoresis indicated that the CBP gene is located on chromosome R (data not shown). The steroid hormones used were as follows: P, progesterone; B, corticosterone; F, cortisol; R5020, promegestrone (a synthetic progestin); Dex, dexamethasone (a synthetic glucocorticoid); DHT, dihydrotestosterone; T, testosterone; 11a-F, lla-cortisol; and E, 17,-estradiol. Proc. Natl. Acad. Sci. USA 90 (1993) 1905 was then used to transform CB023, a strain of S. cerevisiae in which the genes of several proteolytic enzymes are disrujited (33) . As shown in Fig. 4A , the expressed protein displayed a high-affinity binding site for [3H]corticosterone with an equilibrium dissociation constant (Kd) of 7 nM. This value corresponds well with the native C. albicans CBP protein, which displayed a Kd of 6 nM (9). The binding capacity of the over-expressed CBP in S. cerevisiae (170 pmol of [3H]corticosterone bound per mg of protein) was considerably greater than the maximal level of CBP binding found in C. albicans strain STN 1 (0.6 pmol/mg) (9) . In control experiments, S. cerevisiae transfected with vector alone showed no [3H]corticosterone binding.
The steroid binding specificity ofthe expressed protein was determined by competition analysis with a series of steroid hormones (Fig. 4B) . The CBP expressed in S. cerevisiae exhibited a steroid specificity profile that was similar to the pattern observed for native C. albicans CBP (9) . The protein showed high affinity for both corticosterone and progesterone, moderate affinity for cortisol and the synthetic progestin R5020, and negligible affinity for the synthetic glucocorticoid dexamethasone. No competition was observed with testosterone, dihydrotestosterone, or lla-cortisol at the concentrations tested. Also, 17(-estradiol, which binds to an estrogen-binding protein in C. albicans (13), did not compete for the CBP binding site.
Computer Analysis of DNA and Protein Sequence. The nucleotide and protein data bases were searched for sequences similar to the CBP, but no significant matches were found. When the CBP amino acid sequence was specifically compared with the sequences of the glucocorticoid and progesterone receptors as well as with the sequence of corticosteroidbinding globulin, no areas of substantial similarity were uncovered. However, the region between amino acids 8 and 47 showed a high degree of similarity to proteins with NAD-and FAD-binding folds (Fig. 5) . This region contains the canonical dinucleotide binding helix, Gly-Xaa-Gly-Xaa-Xaa-Gly, which is involved in forming hydrogen bonds with the dinucleotide pyrophosphate group (40, 41) . The region forms a (B-sheet-ahelix-3-sheet fold as predicted by Chou-Fasman modeling and contains the characteristic features of the nucleotidebinding "fingerprint sequence," which includes six spatially conserved hydrophobic residues, a hydrophilic residue (lysine) at the beginning ofthe first (3-sheet, and an acidic residue (glutamic acid) located at the C terminus of the second (3-strand (40) . Glutamic acid is the residue often found associated with FAD-binding folds (42) . In addition, a potential nucleotide-binding sequence, Gly-Xaa-Xaa-Xaa-Xaa-GlyLys, is located between amino acids 347 and 353 (41) .
DISCUSSION
The presence of SBPs in unicellular organisms has led us to propose (7) that these proteins may represent ancestral receptors related to the steroid receptor gene superfamily (29) . In this report we describe the cloning and sequencing of the gene encoding one of these binding proteins, the CBP from the dimorphic yeast C. albicans. The DNA sequence and the deduced amino acid sequence ofthe CBP gene exhibit negligible similarity to the steroid receptor genes. We therefore conclude that CBP is unrelated to the steroid receptor gene superfamily. Analysis of the CBP amino acid sequence revealed a highly conserved dinucleotide-binding motif, Gly-Xaa-Gly-XaaXaa-Gly (amino acids [13] [14] [15] [16] [17] [18] , present in NAD-and FADbinding proteins (40, 41) . The presence of a "fingerprint sequence" for a Pap3-fold for dinucleotide binding and a glutamic acid residue at the C terminus of this region (amino acids , which is associated with FAD binding, suggests that the CBP may be a flavin-binding protein. A second potential nucleotide-binding motif matching the consensus sequence Gly-Xaa-Xaa-Xaa-Xaa-Gly-Lys (41) is present at amino acids 347-353. Since NAD/FAD-binding proteins often are oxidoreductases, dehydrogenases, or mixed function oxidases, it is possible that CBP possesses such enzymatic activity and that the steroids that bind to the CBP represent substrates or allosteric effectors for such an enzyme.
Whether or not the SBPs turn out to exhibit enzymatic activity, it should be emphasized that direct biological actions have been shown to be induced by the cognate steroid hormones in three fungal organisms that possess SBPs, estradiol in S. cerevisiae (24) and P. brasieliensis (16, 17, 21, 23) and progesterone in T. mentagrophytes (18) (19) (20) . The functional role of CBP in C. albicans has not yet been elucidated, and whether it is involved in the pathogenicity of this organism remains to be established. However, ketoconazole and related imidazole antifungal drugs are capable of displacing corticosterone from the CBP binding site (11) . These agents derive their antifungal activity by inhibiting selected metabolic enzymes, predominantly cytochrome P450 enzymes (43) . The presence of a dinucleotide-binding site consensus sequence suggests that CBP may exhibit enzymatic activity. This raises the possibility that the postulated enzymatic activity is inhibited by the imidizole antifungal drugs, thus contributing to the antifungal activity of ketoconazole and related agents. If this notion proves to be correct, we speculate that CBP may provide a novel target for the development of new therapeutic agents in the treatment of candidiasis and other fungal diseases.
In conclusion, the gene encoding CBP in C. albicans has been cloned and characterized. Analysis of the available data indicates that CBP is unrelated to the steroid receptor gene superfamily but is most likely a dinucleotide-binding protein, possibly a flavoprotein. We believe that the cloning of the CBP gene will provide the necessary molecular probes to investigate the activity and function of CBP in C. albicans and its potential role in antifungal drug action.
